The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.
Vertex's new cell therapy, made from stem cells, aims to replace insulin-producing cells in people with type 1 diabetes. The therapy will soon begin testing in clinical trials to determine its safety and efficacy. Continue Reading »
To mark the hundredth anniversary of the discovery of insulin, the University of Toronto is hosting a series of presentations and seminars on the latest advances in diabetes treatments. A free, two-day virtual conference in April will feature lectures by more than a dozen experts in diabetes, focusing on the history of insulin, updates in diabetes management, and future research. Continue Reading »
At the ADA Postgraduate 2021 virtual conference, Dr. Samuel Dagogo-Jack discussed how intensive lifestyle changes can lead to prediabetes remission and prevent progression to type 2 diabetes. Continue Reading »
Drug company Lilly released important results showing that the new therapy may be extremely effective for people with type 2 diabetes. Across three clinical trials, tirzepatide reduced A1C by an average of 2.5 percentage points and led to a weight loss of about 25 pounds. Continue Reading »
The RADIANT study aims to define unusual forms of diabetes, to help diagnose and treat these conditions. RADIANT is recruiting people who have been diagnosed with diabetes but don’t fit the usual characteristics of type 1 or type 2 diabetes. Continue Reading »
Recent results from Omada Health’s Digital Diabetes Prevention Program show reductions in A1C and body weight over a 12-month period. This digital tool may be especially helpful for people with prediabetes during COVID-19 Continue Reading »
More people with diabetes are taking drugs like Jardiance and Farxiga, originally developed to lower glucose in people with type 2 diabetes, because the latest data confirms that these drugs can protect your kidneys. A therapy still under investigation, finerenone, has been developed to protect the kidneys of people with and without diabetes Continue Reading »
How might exercise affect your blood glucose? The T1-DEXI study hopes to answer this big question with real-world data from over 600 people with type 1 diabetes – including you! If you have type 1 diabetes and are willing to be active for just 150 minutes each week, this is a unique opportunity to participate remotely in large-scale diabetes research. And, it's quick and easy to sign up! Continue Reading »
